I think MJNA is one of the rare companies on the penny stock exchange that has a legitimate growing business. They mastered product sale and that is the bottom line. They have an army of sale people around the world and their sale capacity will skyrocket in the USA after Hemp legalization. They are also very active in Canada and Mexico and of course in other countries, including eastern Europe and later in 2019 South Korea.
Because of their sale growth, they should put their financial reporting in order and uplist if possible in 2019. They are a perfect company to uplsit because they would gain a lot from it. Some people on the penny stock exchange think if a company submit audited financials and manage to uplist, the problem is solved. No, that is not how it works. After all, the center of gravity of the business is revenue and profit. When you achieve a good growth with potentially becoming profitable as MJNA showed in Q3, then it is time to uplist. If MJNA uplists by the end of 2019 or at least start offering audited financials, their stock will literally skyrocket beyond imagination.
If there is no foul play, I have no doubt that MJNA will become a monstrous company with over a billion dollar in sale by 2022. Park an investment you can afford to lose here and let it ride in the next few years.
MJNA stock could easily reach 0.5 with current AS/OS, then they should do a 20/1 RS, to bring it in the range of $5 to $10, where institutional investors can get in. The sky is the limit from there. They have a golden opportunity to do that. Sale is already on their side and expected to even way much better moving forward, and they mastered it.
News 
Market Data 
Discover 
AI
